Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Netanyahu orders deeper Israeli incursion into Lebanon
Blast in Myanmar village reportedly kills 55 and injures dozens more
US military says it turned away blockade runner trying to reach Iranian port
Two hundred hurt in post-game violence as Paris hails second Champions League triumph
